Login
- Title:
Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial
- Document type:
- Zeitschriftenaufsatz
- Author(s):
- Guttman-Yassky, Emma; Brunner, Patrick M.; Neumann, Avidan U.; Khattri, Saakshi; Pavel, Ana B.; Malik, Kunal; Singer, Giselle K.; Baum, Danielle; Gilleaudeau, Patricia; Sullivan-Whalen, Mary; Rose, Sharon; Jim On, Shelbi; Li, Xuan; Fuentes-Duculan, Judilyn; Estrada, Yeriel; Garcet, Sandra; Traidl-Hoffmann, Claudia; Krueger, James G.; Lebwohl, Mark G.
- Journal title:
- Journal of the American Academy of Dermatology
- Year:
- 2018
- Journal volume:
- 78
- Journal issue:
- 5
- Pages contribution:
- 872-881.e6
- Fulltext / DOI:
- doi:10.1016/j.jaad.2018.01.016
- Publisher:
- Elsevier BV
- E-ISSN:
- 0190-9622
- Date of publication:
- 01.05.2018
BibTeX
Occurrences: